Douglas B. Given, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 4,500 shares at $89.21 ($401K) on 2021-06-22, disclosed to the SEC on 2021-06-24.
Open-market sale of $401k ARWR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARWR | SELL | 2023-05-08 | $266K | — | Filing → |
| ARWR | SELL | 2023-03-01 | $29K | — | Filing → |
| ARWR | BUY | 2021-12-29 | $43K | — | Filing → |